A musical intervention for respiratory comfort during noninvasive ventilation in the ICU.


Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
01 2019
Historique:
received: 15 07 2018
accepted: 31 10 2018
pubmed: 24 12 2018
medline: 2 10 2020
entrez: 23 12 2018
Statut: epublish

Résumé

Discomfort associated with noninvasive ventilation (NIV) may participate in its failure. We aimed to determine the effect of a musical intervention on respiratory discomfort during NIV in patients with acute respiratory failure (ARF).An open-label, controlled trial was performed over three centres. Patients requiring NIV for ARF were randomised to either a musical intervention group (where they received a musical intervention and were subjected to visual deprivation during the first 30 min of each NIV session), a sensory deprivation group (where they wore insulating headphones and were subjected to visual deprivation during the first 30 min of each NIV session), or a control group (where they received NIV as routinely performed). The primary outcome was the change in respiratory discomfort before and after 30 min of the first NIV session.A total of 113 patients were randomised (36 in the musical intervention group, 38 in the sensory deprivation group and 39 in the control group). Median (interquartile range (IQR)) change in respiratory discomfort was 0 (-1; 1) between the musical intervention and control groups (p=0.7). Between groups comparison did not evidence any significant variation of respiratory parameters across time or health-related quality of life (HRQoL) at day-90. The Peri-traumatic Distress Inventory (PDI) at intensive care unit (ICU) discharge was reduced in musical intervention group patients. However, a 30 min musical intervention did not reduce respiratory discomfort during NIV for ARF in comparison to conventional care or sensory deprivation.

Identifiants

pubmed: 30578396
pii: 13993003.01873-2018
doi: 10.1183/13993003.01873-2018
pii:
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Edwige Touré (E)
Sandrine Monot (S)
Damien Roux (D)
Stephane Gaudry (S)
Lucile Leleu (L)
Nathalie Piqueras (N)
Lilia Berrahil-Meksen (L)
Alain Gaffinel (A)
Angélique Deschamps (A)
Magalie Antoine (M)
Aihem Yehia (A)
Isabelle Vinatier (I)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright ©ERS 2019.

Déclaration de conflit d'intérêts

Conflict of interest: J. Messika reports congress fee reimbursement from Fisher and Paykel, outside the submitted work. Conflict of interest: J.-D. Ricard reports congress fee reimbursement from Fisher and Paykel, outside the submitted work.

Auteurs

Jonathan Messika (J)

Medical-Surgical Intensive Care Unit, Hôpital Louis Mourier, AP-HP, Colombes, France.
UMRS 1137 (IAME), Sorbonne Paris Cité, Université Paris Diderot, Paris, France.
UMRS 1137 (IAME), INSERM, Paris, France.

Yolaine Martin (Y)

Medical-Surgical Intensive Care Unit, Hôpital Louis Mourier, AP-HP, Colombes, France.

Natacha Maquigneau (N)

Medical-Surgical Intensive Care Unit, District Hospital Center, La Roche-sur-Yon, France.

Christelle Puechberty (C)

Medical-Surgical Intensive Care Unit, Institut Gustave Roussy, Villejuif, France.

Matthieu Henry-Lagarrigue (M)

Medical-Surgical Intensive Care Unit, District Hospital Center, La Roche-sur-Yon, France.

Annabelle Stoclin (A)

Medical-Surgical Intensive Care Unit, Institut Gustave Roussy, Villejuif, France.

Nataly Panneckouke (N)

Medical-Surgical Intensive Care Unit, Hôpital Louis Mourier, AP-HP, Colombes, France.

Serge Villard (S)

Medical-Surgical Intensive Care Unit, Hôpital Louis Mourier, AP-HP, Colombes, France.

Aline Dechanet (A)

Unité de Recherche Clinique Paris-Nord, Hôpital Bichat, AP-HP, Paris, France.

Alexandre Lafourcade (A)

Dépt de Biostatistiques, Santé Publique et Information Médicale, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.

Didier Dreyfuss (D)

Medical-Surgical Intensive Care Unit, Hôpital Louis Mourier, AP-HP, Colombes, France.
UMRS 1137 (IAME), Sorbonne Paris Cité, Université Paris Diderot, Paris, France.
UMRS 1137 (IAME), INSERM, Paris, France.

David Hajage (D)

Dépt de Biostatistique, Santé Publique et Information Médicale, Centre de Pharmaco-Epidémiologie de l'AP-HP, Sorbonne Université, CIC 1421, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
UMRS 1123 (ECEVE), CIC-EC 1425, INSERM, Paris, France.

Jean-Damien Ricard (JD)

Medical-Surgical Intensive Care Unit, Hôpital Louis Mourier, AP-HP, Colombes, France.
UMRS 1137 (IAME), Sorbonne Paris Cité, Université Paris Diderot, Paris, France.
UMRS 1137 (IAME), INSERM, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH